The West Midlands is a leader in medical technology, and with plans to further develop the biotech sector in the region and country, the growth of corporate venture capital is an important feature of this growth. Here we highlight a paper exploring the relationship between corporate venture capital (CVC) and the University of Cambridge. The paper published in Bioentrepreneur provides good advice for biotech startups especially for those seeking to emerge out of universities in the West Midlands.

Fostering industry partnerships to drive academic entrepreneurship in the current, extremely competitive funding environment requires a scientifically driven approach. Research universities are increasingly looking to alternative bodies for funding sources and, as a result, the pharmaceutical industry has become inundated with investment opportunities. To differentiate their venture pitch, universities must build a strong business case to communicate where a discovery fits in the scientific portfolio of a potential industry partner. CVC alone will not address the academic valley of death, but industry’s combination of funding and commercial expertise offers an orthogonal value add to academic excellence.

You can read the full text of the article here.

There are also important events for biotech entrepreneurs being held around the country organised by Oxbridge Biotech Roundtable. These events will discuss the world’s largest Biotech Business Plan Competition. The nearest events to Birmingham will be held in Manchester and Oxford:

OneStart is calling all young innovators from Oxford and other places to come to the OneStart launch event in Oxford. We will tell you how to enter the world’s largest life science business plan competition/accelerator program, OneStart. The mission of the competition is to help you to realize your innovative ideas advancing healthcare. The winner will receive £100k, free lab space near London, and ongoing business advice.

About the OneStart competition:
Applications are open from 1st October until 1st December 2014. We welcome applications from individuals or teams (up to 6 team members). We encourage you to recruit other scientists, engineers, business students, lawyers, and anyone else with talent and motivation to execute a great idea, so don’t forget to browse through our co-founders hub. We welcome ideas at all stages of development.

Our 35 semi-finalists will be directly mentored by experienced industry professionals, connected with venture capital, pharmaceutical, and biotech executives, and invited to attend a Business Bootcamp in London with workshops from our global sponsors, including SR One (the corporate venture capital arm of GSK), Johnson & Johnson Innovation, Takeda, Roche, McKinsey, and others. OneStart will be open to applicants aged 35 and under (as of 31st December 2014).

For more details about the OneStart competition see: www.oxbridgebiotech.com/onestart/